Dataset Information

Amino Acid derivatives as new zinc binding groups for the design of selective matrix metalloproteinase inhibitors.

ABSTRACT: A number of matrix metalloproteinases (MMPs) are important medicinal targets for conditions ranging from rheumatoid arthritis to cardiomyopathy, periodontal disease, liver cirrhosis, multiple sclerosis, and cancer invasion and metastasis, where they showed to have a dual role, inhibiting or promoting important processes involved in the pathology. MMPs contain a zinc (II) ion in the protein active site. Small-molecule inhibitors of these metalloproteins are designed to bind directly to the active site metal ions. In an effort to devise new approaches to selective inhibitors, in this paper, we describe the synthesis and preliminary biological evaluation of amino acid derivatives as new zinc binding groups (ZBGs). The incorporation of selected metal-binding functions in more complex biphenyl sulfonamide moieties allowed the identification of one compound able to interact selectively with different MMP enzymatic isoforms.

SUBMITTER: Giustiniano M

PROVIDER: S-EPMC3608355 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Amino Acid derivatives as new zinc binding groups for the design of selective matrix metalloproteinase inhibitors.

Giustiniano Mariateresa M Tortorella Paolo P Agamennone Mariangela M Di Pizio Antonella A Rossello Armando A Nuti Elisa E Gomez-Monterrey Isabel I Novellino Ettore E Campiglia Pietro P Vernieri Ermelinda E Sala Marina M Bertamino Alessia A Carotenuto Alfonso A

Journal of amino acids 20130310

A number of matrix metalloproteinases (MMPs) are important medicinal targets for conditions ranging from rheumatoid arthritis to cardiomyopathy, periodontal disease, liver cirrhosis, multiple sclerosis, and cancer invasion and metastasis, where they showed to have a dual role, inhibiting or promoting important processes involved in the pathology. MMPs contain a zinc (II) ion in the protein active site. Small-molecule inhibitors of these metalloproteins are designed to bind directly to the active ...[more]

PMID: 23555050

Dataset Information

Amino Acid derivatives as new zinc binding groups for the design of selective matrix metalloproteinase inhibitors.

Publications

Amino Acid derivatives as new zinc binding groups for the design of selective matrix metalloproteinase inhibitors.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Similar Datasets

Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 Inhibitors.
| S-EPMC6420151 | biostudies-literature

Synthesis of HDAC Substrate Peptidomimetic Inhibitors Using Fmoc Amino Acids Incorporating Zinc-Binding Groups.
| S-EPMC6503537 | biostudies-literature

Zinc binding groups for histone deacetylase inhibitors.
| S-EPMC6009916 | biostudies-literature

Zinc-binding groups modulate selective inhibition of MMPs.
| S-EPMC2836234 | biostudies-literature

Binding of matrix metalloproteinase inhibitors to extracellular matrix: 3D-QSAR analysis.
| S-EPMC2896061 | biostudies-literature

Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.
| S-EPMC4255739 | biostudies-literature

N <i><sup>ɛ</sup></i> -acetyl lysine derivatives with zinc binding groups as novel HDAC inhibitors.
| S-EPMC6599804 | biostudies-literature

Inhibition of bovine nasal cartilage degradation by selective matrix metalloproteinase inhibitors.
| S-EPMC1218345 | biostudies-other

Identification of Zinc-Binding Inhibitors of Matrix Metalloproteinase-9 to Prevent Cancer Through Deep Learning and Molecular Dynamics Simulation Approach.
| S-EPMC9024349 | biostudies-literature

Triple-helical transition state analogues: a new class of selective matrix metalloproteinase inhibitors.
| S-EPMC2531068 | biostudies-literature